Patents by Inventor Päivi Lindholm

Päivi Lindholm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT WITH A PHARMACEUTICAL COMPOSITION COMPRISING MANF2 NUCLEIC ACID
    Publication number: 20190153052
    Abstract: A method for treating a condition in a patient, wherein the condition is selected from the group consisting of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, stroke and peripheral neuropathy. The method consists of administering to the patient a pharmaceutically effective amount of a pharmaceutical composition comprising the MANF2 polypeptide of SEQ ID NO:2 or a functional fragment thereof.
    Type: Application
    Filed: October 17, 2014
    Publication date: May 23, 2019
    Applicant: HERANTIS PHARMA PLC.
    Inventors: Mart SAARMA, Juha LAUREN, Päivi LINDHOLM, Tonis TIMMUSK, Raimo TUOMINEN
  • Treatment with a pharmaceutical composition comprising MANF2 necleic acid
    Patent number: 8980821
    Abstract: A method for treating a condition in a patient, wherein the condition is selected from the group consisting of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, stroke and peripheral neuropathy. The method consists of administering to the patient a pharmaceutically effective amount of a pharmaceutical composition comprising the MANF2 polypeptide of SEQ ID NO:2 or a functional fragment thereof.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: March 17, 2015
    Assignee: Herantis Pharma Oyj
    Inventors: Mart Saarma, Juha Lauren, Päivi Lindholm, Tonis Timmusk, Raimo Tuominen
  • NEUROTROPHIC FACTOR MANF AND USES THEREOF
    Publication number: 20150020222
    Abstract: The present invention generally relates to the field of treatment of neuronal disorders and more particularly to neurotrophic factor MANF and uses thereof. The present invention provides a pharmaceutical compound comprising MANF nucleic acid molecule, MANF protein or a functional fragment thereof for the treatment of a peripherial neuropathy including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction and ischemic brain injury.
    Type: Application
    Filed: September 9, 2014
    Publication date: January 15, 2015
    Applicant: HERANTIS PHARMA, PLC.
    Inventors: Mart SAARMA, Päivi LINDHOLM, Merja VOUTILAINEN, Johan PERÄNEN, Raimo TUOMINEN, Mikko AIRAVAARA, Veli-Matti LEPPÄNEN, Maria LINDAHL, Jaan-Olle ANDRESSOO
  • Neurotrophic factor MANF and uses thereof
    Patent number: 8853166
    Abstract: The present invention generally relates to the field of treatment of neuronal disorders and more particularly to neurotrophic factor MANF and uses thereof. The present invention provides a pharmaceutical compound comprising MANF nucleic acid molecule, MANF protein or a functional fragment thereof for the treatment of a peripherial neuropathy including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction and ischemic brain injury.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: October 7, 2014
    Assignee: Herantis Pharma PLC.
    Inventors: Mart Saarma, Päivi Lindholm, Merja Voutilainen, Johan Peränen, Raimo Tuominen, Mikko Airavaara, Veli-Matti Leppänen, Maria Lindahl, Jaan-Olle Andressoo
  • TREATMENT WITH A PHARMACEUTICAL COMPOSITION COMPRISING MANF2 NUCLEIC ACID
    Publication number: 20110251132
    Abstract: A method for treating a condition in a patient, wherein the condition is selected from the group consisting of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, stroke and peripheral neuropathy. The method consists of administering to the patient a pharmaceutically effective amount of a pharmaceutical composition comprising the MANF2 polypeptide of SEQ ID NO:2 or a functional fragment thereof.
    Type: Application
    Filed: April 15, 2011
    Publication date: October 13, 2011
    Inventors: Mart SAARMA, Juha Lauren, Päivi Lindholm, Tonis Timmusk, Raimo Tuominen
  • Neurotrophic factor protein and uses thereof
    Patent number: 7452969
    Abstract: The present invention discloses a novel neurotrophic factor protein, MANF2 and a genetic sequence encoding the same. The molecule will be useful in the development of a range of therapeutics and diagnostics useful in the treatment, prophylaxis and/or diagnosis of MANF2 dependent conditions. The molecule of the present invention is also a useful effector of primary and central neurons, especially dopaminergic neurons at the central nervous system and growth factor genes.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: November 18, 2008
    Assignee: Licentia Ltd
    Inventors: Mart Saarma, Juha Lauren, Päivi Lindholm, Tonis Timmusk, Raimo Tuominen